SCHEMBL6590209

SCHEMBL6590209

CC(C)S(=O)(=O)N1CCN(c2ccnc([C@@H](C)O)n2)CC1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SORD Q00796 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6585364 0.85 SORD (1.00) SORD
Dimethylamine SCHEMBL7930897 0.85 SORD (0.70) SORD
SCHEMBL6586568 0.85 SORD (1.00) SORD
SCHEMBL6585366 0.85 SORD (1.00) SORD
SCHEMBL6294667 0.79 SORD (0.63) SORD
SCHEMBL6586699 0.79 SORD (0.52) SORD
SCHEMBL6586693 0.79 SORD (0.52) SORD
SCHEMBL6293156 0.78 SORD (0.61) SORD
SCHEMBL6293155 0.78 SORD (0.61) SORD
SCHEMBL7567235 0.73 SORD (1.00) SORD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1041068-B1 Compounds for treating and preventing diabetic complications PFIZER PROD INC (US) 2004-04-14 EP disclosed
EP-1041068-A1 Compounds for treating and preventing diabetic complications Pfizer Products Inc. (US) 2000-10-04 EP disclosed